LAHORE: The Punjab government announced on Friday that those seeking assistance under the Nighaban Ramazan package should get themselves registered by Feb 15. It also announced that registration ...

DAVOS, Switzerland, Jan 24 (Reuters) - Saudi Economy Minister Faisal Alibrahim said on Friday that the kingdom's $600 billion expanded package with the United States includes investments as well ...

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...

We investigated whether patients with inflammatory bowel disease treated with infliximab have attenuated serological responses to a single dose of a SARS-CoV-2 vaccine. Design Antibody responses and ...

Objective Although low infliximab trough concentrations and antibodies to infliximab (ATI) are associated with poor outcomes in patients with Crohn's disease (CD), the clinical relevance of ATI in ...

Early referral (at <3 months) and early DMARD treatment enable the course of RA to be changed. Once the disease has become aggressive it is much harder to treat and improvements will not be as great ...

This repository contains the manifest files for the Windows Package Manager default source. You are highly encouraged to submit manifests for your favorite application. This project welcomes ...

These results partly correlate with the common adverse reactions listed in the drug’s package insert, indicating high credibility of the data. Notably, some of the SOCs involve significant adverse ...

People with inflammatory bowel disease (IBD) may be at an increased risk for complications from the flu (influenza). That's because IBD affects the immune system, and medications used to treat ...

3 If after 3 months the patient still does not show improvement on multiple DMARD therapy, then the addition of a biologic is recommended starting with an anti-TNF such as Enbrel, Humira, Cimzia, ...

Department of Thoracic Oncology, Jiangxi Cancer Hospital & Institute, Jiangxi Clinical Research Center for Cancer, The second Affiliated Hospital of Nanchang Medical College, Nanchang, China ...